ACAD9 and hyperinsulinemic hypoglycemia, familial, 4: Our retrospective data provides additional description of the clinical and genetic spectrum of ACAD9 deficiency, and provides valuable insight for the development of future clinical trials of riboflavin, bezafibrate, or other therapies.